MedTrace Logo

Effect of a Single Immersive Virtual Reality Session on Preoperative Surgical Fear and State Anxiety

NCT07774156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-08-20

No results posted yet for this study

Summary

To determine whether a single 20-minute immersive VR nature session delivered in the immediate preoperative period reduces surgical fear and state anxiety in patients scheduled for bariatric surgery.

Conditions

  • Virtual Reality
  • Surgical Fear Scale
  • Anxiety

Interventions

BEHAVIORAL

Experimental Group

Patients viewed 360° nature footage of forest, sea and landscape scenes, selected to be relaxing and to contain no threatening or surgery-related content and accessed through a publicly available video platform. The session lasted 20 minutes and was delivered by the researcher in the patient's own room, from which noise and interruptions were excluded. A duration of 20 minutes was chosen because relaxation-focused VR sessions of roughly 15 to 40 minutes are those most commonly reported to be effective and well tolerated, whereas longer exposures increase the risk of cybersickness . Post-test measures were administered 10 minutes after the session ended. Among the 60 patients who received the intervention, no adverse effects such as nausea, dizziness or disorientation were reported and no session was interrupted.

Sponsors & Collaborators

  • Firat University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-10
Primary Completion
2026-06-10
Completion
2026-07-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07774156 on ClinicalTrials.gov